PL2059513T3 - Sposób wytwarzania pochodnych 1,2,4-oksadiazolowych kwasu benzoesowego - Google Patents
Sposób wytwarzania pochodnych 1,2,4-oksadiazolowych kwasu benzoesowegoInfo
- Publication number
- PL2059513T3 PL2059513T3 PL07837899T PL07837899T PL2059513T3 PL 2059513 T3 PL2059513 T3 PL 2059513T3 PL 07837899 T PL07837899 T PL 07837899T PL 07837899 T PL07837899 T PL 07837899T PL 2059513 T3 PL2059513 T3 PL 2059513T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- benzoic acids
- oxadiazole benzoic
- oxadiazole
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84359506P | 2006-09-08 | 2006-09-08 | |
| EP07837899A EP2059513B1 (en) | 2006-09-08 | 2007-09-06 | Process for the preparation of 1,2,4-oxadiazole benzoic acids |
| PCT/US2007/019561 WO2008030570A1 (en) | 2006-09-08 | 2007-09-06 | Processes for the preparation of 1,2,4-oxadiazole benzoic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2059513T3 true PL2059513T3 (pl) | 2013-06-28 |
Family
ID=38935880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07837899T PL2059513T3 (pl) | 2006-09-08 | 2007-09-06 | Sposób wytwarzania pochodnych 1,2,4-oksadiazolowych kwasu benzoesowego |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7678922B2 (pl) |
| EP (1) | EP2059513B1 (pl) |
| JP (2) | JP5955494B2 (pl) |
| KR (1) | KR101466368B1 (pl) |
| CN (1) | CN101535284B (pl) |
| AR (3) | AR062715A1 (pl) |
| AU (1) | AU2007292915B2 (pl) |
| BR (1) | BRPI0716996B8 (pl) |
| CA (2) | CA2662749C (pl) |
| CL (1) | CL2007002606A1 (pl) |
| DK (1) | DK2059513T3 (pl) |
| ES (1) | ES2404348T3 (pl) |
| HK (1) | HK1134094A1 (pl) |
| IL (1) | IL197445A (pl) |
| MX (1) | MX2009002439A (pl) |
| MY (1) | MY148598A (pl) |
| NZ (2) | NZ598012A (pl) |
| PE (2) | PE20080771A1 (pl) |
| PL (1) | PL2059513T3 (pl) |
| PT (1) | PT2059513E (pl) |
| RU (1) | RU2495030C2 (pl) |
| TW (1) | TWI482761B (pl) |
| UA (1) | UA99265C2 (pl) |
| WO (1) | WO2008030570A1 (pl) |
| ZA (1) | ZA200901782B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3345895T1 (sl) | 2003-04-11 | 2020-03-31 | Ptc Therapeutics, Inc. | Spojina 1,2,4-oksadiazol benzojske kisline in njena uporaba za supresijo nesmiselne in zdravljenje bolezni |
| ES2390804T3 (es) | 2005-04-08 | 2012-11-16 | Ptc Therapeutics, Inc. | Composiciones de un 1,2,4-oxadiazol oralmente activo para terapia de supresión de la mutación sin sentido |
| EP2387995A1 (en) * | 2006-03-30 | 2011-11-23 | PTC Therapeutics, Inc. | Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith |
| ZA200901782B (en) * | 2006-09-08 | 2010-06-30 | Ptc Therapeutics Inc | Processes for the preparation of 1, 2, 4-oxadiazole benzoic acids |
| EP2068871B1 (en) | 2006-09-25 | 2013-12-25 | PTC Therapeutics, Inc. | Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression |
| EP2559689B1 (en) * | 2006-09-25 | 2017-11-29 | PTC Therapeutics, Inc. | Preparation process for crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]benzoic acid |
| RS54025B1 (en) | 2006-10-12 | 2015-10-30 | Ptc Therapeutics Inc. | DOSAGE PROCEDURES FOR ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENS MUTATION SUPPRESSION THERAPY |
| CN101714009A (zh) * | 2009-05-14 | 2010-05-26 | 翁印嵩 | 集成通用电话功能的计算机 |
| WO2012101292A1 (es) | 2011-01-25 | 2012-08-02 | Viviabiotech, S.L. | Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1 |
| US9040711B2 (en) | 2012-07-02 | 2015-05-26 | Monsanto Technology Llc | Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles |
| CA2942147C (en) | 2014-03-06 | 2022-12-13 | Ptc Therapeutics, Inc. | Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid |
| CN105461650B (zh) * | 2014-09-12 | 2018-04-13 | 杭州普晒医药科技有限公司 | 一种噁二唑化合物的溶剂化物及其制备方法 |
| CN106316885B (zh) * | 2015-07-03 | 2019-02-12 | 普济生物科技（台州）有限公司 | 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法 |
| AR106530A1 (es) | 2015-10-30 | 2018-01-24 | Ptc Therapeutics Inc | Métodos para tratar epilepsia |
| TW201808922A (zh) | 2016-06-20 | 2018-03-16 | 台灣神隆股份有限公司 | 製備阿塔魯仁及其中間體的方法 |
| US20220071965A1 (en) | 2018-12-20 | 2022-03-10 | Pfizer Inc. | Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent |
| WO2022112919A1 (en) | 2020-11-25 | 2022-06-02 | Pfizer Inc. | (aza)benzothiazolyl substituted pyrazole compounds |
| CN113045510B (zh) * | 2021-03-31 | 2022-05-27 | 北京大学生命科学华东产业研究院 | 一种阿塔鲁伦的制备方法 |
| CN114920667B (zh) * | 2022-06-30 | 2024-06-21 | 湖南大学 | 一种阿塔鲁伦酯的电化学制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
| DE3905242A1 (de) * | 1989-02-21 | 1990-08-23 | Basf Ag | Verfahren zur herstellung von phenyloxdiazolylanilinen |
| NZ234760A (en) * | 1989-08-18 | 1991-09-25 | Sterling Drug Inc | Antiviral oxazole compounds and compositions |
| DE4425794A1 (de) * | 1994-07-21 | 1996-01-25 | Basf Ag | Nitrofarbstoffe |
| US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| CA2449544A1 (en) | 2001-06-08 | 2002-12-19 | Cytovia, Inc. | Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs |
| MY151199A (en) | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
| MXPA05001592A (es) | 2002-08-09 | 2005-05-05 | Astrazeneca Ab | Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico. |
| GB0303503D0 (en) | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| SI3345895T1 (sl) * | 2003-04-11 | 2020-03-31 | Ptc Therapeutics, Inc. | Spojina 1,2,4-oksadiazol benzojske kisline in njena uporaba za supresijo nesmiselne in zdravljenje bolezni |
| WO2004110351A2 (en) | 2003-05-14 | 2004-12-23 | Anadys Pharmaceuticals, Inc. | Heterocyclic compounds for treating hepatitis c virus |
| ES2390804T3 (es) | 2005-04-08 | 2012-11-16 | Ptc Therapeutics, Inc. | Composiciones de un 1,2,4-oxadiazol oralmente activo para terapia de supresión de la mutación sin sentido |
| ZA200901782B (en) * | 2006-09-08 | 2010-06-30 | Ptc Therapeutics Inc | Processes for the preparation of 1, 2, 4-oxadiazole benzoic acids |
-
2007
- 2007-09-06 ZA ZA200901782A patent/ZA200901782B/xx unknown
- 2007-09-06 NZ NZ598012A patent/NZ598012A/xx unknown
- 2007-09-06 CA CA2662749A patent/CA2662749C/en active Active
- 2007-09-06 PT PT78378999T patent/PT2059513E/pt unknown
- 2007-09-06 PL PL07837899T patent/PL2059513T3/pl unknown
- 2007-09-06 RU RU2009113019/04A patent/RU2495030C2/ru active
- 2007-09-06 UA UAA200903350A patent/UA99265C2/ru unknown
- 2007-09-06 KR KR1020097007202A patent/KR101466368B1/ko active IP Right Grant
- 2007-09-06 JP JP2009527430A patent/JP5955494B2/ja active Active
- 2007-09-06 NZ NZ575511A patent/NZ575511A/en unknown
- 2007-09-06 MX MX2009002439A patent/MX2009002439A/es active IP Right Grant
- 2007-09-06 DK DK07837899.9T patent/DK2059513T3/da active
- 2007-09-06 ES ES07837899T patent/ES2404348T3/es active Active
- 2007-09-06 AU AU2007292915A patent/AU2007292915B2/en active Active
- 2007-09-06 CN CN200780041169.XA patent/CN101535284B/zh active Active
- 2007-09-06 WO PCT/US2007/019561 patent/WO2008030570A1/en active Application Filing
- 2007-09-06 US US11/899,813 patent/US7678922B2/en active Active - Reinstated
- 2007-09-06 BR BRPI0716996A patent/BRPI0716996B8/pt active IP Right Grant
- 2007-09-06 MY MYPI20090941A patent/MY148598A/en unknown
- 2007-09-06 CA CA2842625A patent/CA2842625C/en active Active
- 2007-09-06 EP EP07837899A patent/EP2059513B1/en active Active
- 2007-09-07 AR ARP070103975A patent/AR062715A1/es not_active Application Discontinuation
- 2007-09-07 TW TW096133607A patent/TWI482761B/zh active
- 2007-09-07 PE PE2007001203A patent/PE20080771A1/es active IP Right Grant
- 2007-09-07 PE PE2011001405A patent/PE20120669A1/es active IP Right Grant
- 2007-09-07 CL CL200702606A patent/CL2007002606A1/es unknown
-
2009
- 2009-03-05 IL IL197445A patent/IL197445A/en active IP Right Grant
- 2009-11-13 US US12/617,757 patent/US8367841B2/en active Active
-
2010
- 2010-03-01 HK HK10102172.4A patent/HK1134094A1/xx unknown
-
2014
- 2014-05-20 JP JP2014103966A patent/JP2014193896A/ja active Pending
-
2017
- 2017-01-27 AR ARP170100223A patent/AR107474A2/es not_active Application Discontinuation
-
2020
- 2020-05-12 AR ARP200101362A patent/AR118922A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2059513T3 (pl) | Sposób wytwarzania pochodnych 1,2,4-oksadiazolowych kwasu benzoesowego | |
| DK3872059T3 (en) | Process for the preparation of 2,3,3,3 tetrahydrofluoropropene | |
| PL1993985T3 (pl) | Sposób wytwarzania 1,2-propanodiolu | |
| IL195178A0 (en) | 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments | |
| IL195177A0 (en) | 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments | |
| IL195176A0 (en) | 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments | |
| ZA201008097B (en) | Process for the preparation of 2,3,3,3-trifluoropropene | |
| IL226411A (en) | Methods for the preparation of benzoic acids of cycloalkylcarboxamide-Friedin | |
| HK1201822A1 (en) | Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds 56--1h--2- | |
| IL198847A0 (en) | New process for the preparation of 2-imino-thiazolidin-4-one derivatives | |
| EP1922345A4 (en) | PROCESS FOR THE PREPARATION OF COPOLYMER-1 | |
| ZA200805006B (en) | 1,3-Dioxane carboxylic acids | |
| EP2137152A4 (en) | NEW BENZAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| ZA200804264B (en) | Process for the preparation of ferri-succinylcasein | |
| IL180311A0 (en) | Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters | |
| HK1144682A1 (en) | Process for the preparation of alkyl 3,3-dialkoxypropionates 33- | |
| EP1939170A4 (en) | PROCESS FOR PREPARING GABAPENTINE HYDROCHLORIDE | |
| ZA200601910B (en) | Process for the preparation of organosilances | |
| EP2083003A4 (en) | PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTACHLOROBUTANE | |
| IL190325A (en) | A process for making loopfin | |
| IL185335A0 (en) | Process for the preparation of substituted benzoxazole compounds | |
| GB0600712D0 (en) | Process for the manufacture of substituted propionic acids | |
| EP1996192A4 (en) | PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4 | |
| IL199239A0 (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6- | |
| IL198603A0 (en) | Process for the preparation of biphosphonic acids and salts thereof |